The possible existence of nitroimidazole resistance in trichomonads has received much attention. A major approach to the study of this problem is provided by attempts to develop resistant strains experimentally with in vivo or in vitro drug pressure. Recently we developed, with in vivo exposure to metronidazole, a Tritrichomonas foetus strain that exhibits a high level of resistance to several 5-nitroimidazoles, as demonstrated in mice and in vitro tests (12) . Similar observations were made also in a T. foetus strain in which resistance was induced in hamsters (1) . In contrast, Benazet and Guillaume (2) and de Carneri et al. (4) observed in vivo resistance only and no significant in vitro resistance in Trichomonas vaginalis strains in which metronidazole or nimorazole resistance was induced in vivo. The latter authors thus questioned the value of the in vitro test in establishing the metronidazole susceptibility of fresh clinical isolates. The reasons for the discrepancies could lie in differences in the assay methods used. The effects of the medium and its components, as well as PO2, were reported to influence the in vitro efficacy of metronidazole (3, 13, 16) .
In this paper we demonstrate that in our resistant T. foetus strain the in vitro demonstration of resistance strongly depends on the assay method used. Preliminary results were reported previously (J. G. Meingassner 
RESULTS
The results are summarized in Table 1 . It can be seen that the aerobic tray test is the only type of assay system in which a decreased susceptibility of the in vivo metronidazole-resistant strain could be detected with nonmodified media. The only exception was the complete CACH (15) medium, in which no difference was seen. One major difference between this and the other media was in the ascorbate content. Therefore, the effect of ascorbic acid was tested. Addition of ascorbic acid to TTYS (8) and fluid thioglycolate media led to increased susceptibility of the resistant strain, whereas the omission of ascorbic acid permitted demonstration of the resistance of the KV,/ M100 strain also in the CACH medium.
The tube test and anaerobic tray test did not reveal any differences in the metronidazole susceptibility of the two strains.
DISCUSSION
The present work demonstrates that the test methods used will determine whether one can demonstrate in vitro the resistance of an in vivo nitroimidazole-resistant T. foetus strain. One of the major conclusions is that in the absence, or at low concentrations ('0.02%), of (6, (9) (10) (11) 14) , and thus the biological efficacy of these compounds depends on the intracellular availability of "reducing power," possibly the availability ofreduced low-redox-potential electron transport proteins similar to ferredoxin (14) . Since the presence of oxygen is necessary for the in vitro expression of resistance and since this aerobic expression can be suppressed by ascorbate, a strong reducing agent, it is tempting to assume that one of the differences between the resistant and susceptible strains is in their ability to regulate their intracellular redox conditions. This assumption is being probed in our laboratories.
Since the mode of action of metronidazole seems to be similar in T. foetus and T. vaginalis (5, 10, 11, 14) , it is possible that these findings also apply to the latter species. If so, they could go far in explaining why the in vivo resistance of some T. vaginalis strains was not observed in in vitro assays. At the same time they suggest that some reevaluation of published data on the metronidazote susceptibility of T. vaginalis isolates might be necessary and that the development of an in vitro assay more closely reflecting in vivo conditions could be of practical significance.
